U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT07572071) titled 'Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease' on April 07.
Brief Summary: Dopason is a phase I, open-label, multicenter, single-arm clinical trial designed to evaluate the safety and feasibility of intraputaminal transplantation of human embryonic stem cell-derived dopaminergic progenitor cells (DopaCells) in patients with moderately severe Parkinson's disease.
Study Start Date: Aug. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Parkinson Disease (PD)
Intervention:
BIOLOGICAL: Dopacell
DopaCells are dopamine-producing progenitor cells generated from human embryonic stem cells ...